DARIN OLDE: Open Payments
NPI 1699054478 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,840 in 64 payments from 31 companies in 2025. Trend: 2023 $3,498 · 2024 $2,453 · 2025 $1,840
Food & beverage: $1,653Education: $187
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $254 |
| AstraZeneca Pharmaceuticals LP | 5 | $192 |
| Astellas Pharma US Inc | 5 | $144 |
| E.R. Squibb & Sons, L.L.C. | 4 | $125 |
| Merck Sharp & Dohme LLC | 4 | $108 |
| PFIZER INC. | 4 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $76 |
| Deciphera Pharmaceuticals Inc. | 2 | $67 |
| GENZYME CORPORATION | 2 | $62 |
Products named: RYBREVANT, OPDIVO, KEYTRUDA, IMFINZI, QINLOCK, SARCLISA, LIBTAYO, KISQALI.
Industry payments across NV — which companies pay providers there.
